Xuanzhu Biopharmaceutical
As of the edition of 20 October 2026, Xuanzhu Biopharmaceutical runs 9 drugs.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Drugs by status
| Status | Count |
|---|---|
| Active | 3 |
| Status not established | 6 |
| Total | 9 |
Where its trials are
- Digestive system: 5 trials led
- Cancer: 2 trials led
- Lungs and airways: 2 trials led